Litcius/Paper detail

Aortic valve endocarditis in patients with bicuspid and tricuspid aortic valves

Tan Le, Nathan J. Graham, Aroma Naeem, Jeffrey Clemence, Juan J. Cáceres, Xiaoting Wu, Himanshu J. Patel, Karen M. Kim, G. Michael Deeb, Bo Yang

2021JTCVS Open15 citationsDOIOpen Access PDF

Abstract

Objective: To determine the long-term survival and rate of reoperation after surgical treatment of infective endocarditis (IE) in patients with a bicuspid aortic valve (BAV) and patients with a tricuspid aortic valve (TAV). Methods: Between 1997 and 2017, 210 patients underwent surgical treatment for native aortic valve endocarditis, including 51 patients with BAV (24%) and 159 patients with TAV (76%). Data were obtained from the Society of Thoracic Surgeons data warehouse and hospital medical record review, supplemented with surveys and national death index data for more complete follow-up. Results: = .11) for BAV. Conclusions: BAV patients develop IE requiring surgery at a younger age than TAV patients, but have significantly better long-term survival. Early detection of BAV is important to prevent IE and provide aggressive surgical treatment should IE occur.

Topics & Concepts

MedicineInternal medicineCardiologyBicuspid aortic valveHazard ratioOdds ratioEndocarditisInfective endocarditisStroke (engine)Heart failureAortic valveBicuspid valveDialysisTricuspid valveCoronary artery diseaseSurgeryMortality rateConfidence intervalMechanical engineeringEngineeringInfective Endocarditis Diagnosis and ManagementInfectious Aortic and Vascular ConditionsAortic Disease and Treatment Approaches
Aortic valve endocarditis in patients with bicuspid and tricuspid aortic valves | Litcius